gene therapy 2 webinar flyer

RESTORE looks forward to welcoming you to our next online event

Gene Therapy 2.0

29 September 2021, 2:00 – 6:00 PM CET – Webinar event

The event will be chaired by Prof. Hildegard Büning (Institute of Experimental Hematology, Hannover Medical School, Hannover, Germany)

Please keep checking back for more news and updates concerning the Gene Therapy 2.0 Webinar

  Gene Therapy 2.0 Webinar overview and agenda


Overview

Although COVID-19 continues to dominate news channels and social media as well as the interest of public, medical and research communities, research has not stopped on breakthrough technologies and transformative medicine in other indications. Indeed, research continues at full force in academic as well as industry settings on non-COVID-19 topics to ensure continued advancement and development across the board. One of the fields in which intense research and economic activity is evident, is the field of gene therapy. More and more gene therapies are entering the market or are in late clinical development stages, for example Zynteglo (beta thalassemia), Luxturna (inherited retinal disease, Leber congenital amaurosis) and Strimvelis (severe combined immunodeficiency due to adenosine deaminase deficiency). This so-called “classical gene therapy” has established itself as a recognized alternative to older treatment modalities.

However, scientists at the forefront of gene therapy research do not only think about the present, but also about the future, planning for the years ahead and already working to shape the next generation of gene therapies, expanding the realm of what will be scientifically and medically possible.

RESTORE will be hosting a half-day online seminar entitled Gene Therapy 2.0 on 29th September 2021 with the intention of engaging and informing academic and industry institutions as well as patient networks, about the most recent updates and opportunities in gene therapy approaches. We hope the seminar, chaired by Prof. Hildegard Büning, will prove informative to those already in the field, foment new connections and inspire others to consider the possibilities for their own research.

Join us online on 29th September 2021 to take a peek into the future!

Confirmed Speakers

  • Hildegard Büning
    Institute of Experimental Hematology, Hannover Medical School, Hannover, Germany
  • Nathalie Cartier
    Paris Brain Institute (ICM), Sorbonne University, University Hospital Pitié-Salpêtrière, Paris, France
  • Vincenzo Cerullo
    Laboratory of Immunovirotherapy, Drug Research Program, University of Helsinki, Finland
  • Luigi Naldini
    San Raffaele Telethon Institute for Gene Therapy and San Raffaele University Medical School, Milan, Italy
  • Jude Samulski
    Gene Therapy Center, UNC School of Medicine, NC, United States
  • Axel Schambach
    Institute of Experimental Hematology, Hannover Medical School, Hannover, Germany
  • Hans Dieter Volk
    IMI, BCRT, Charité Universitaetsmedizin, Berlin